-
1
Vaccines: The Health of Nations
Published 2022Subjects: “…Plants, Arabidopsis, Viral Antigens, Viral Vectors, Transgenic Plants, Vaccination, Immunization, SARS-CoV-2, Ebola, Marburg, Noro Virus, Molecular Virology…”
Get full text
Presentation -
2
Should we allocate more COVID-19 vaccine doses to non-vaccinated individuals?
Published 2022“…<jats:p>Following the approval by the FDA of two COVID-19 vaccines, which are administered in two doses three to four weeks apart, we simulate the effects of various vaccine distribution policies on the cumulative number of infections and deaths in the United States in the presence of shocks to the supply of vaccines. …”
Get full text
Article -
3
-
4
Synthetic Nanoparticles for Vaccines and Immunotherapy
Published 2017Get full text
Get full text
Get full text
Article -
5
Controlling timing and location in vaccines
Published 2020“…Vaccines are one of the most powerful technologies supporting public health. …”
Get full text
Article -
6
Incorporating Equity into Vaccine Access
Published 2023“…COVID-19 vaccine access inequity was a major challenge during the pandemic. …”
Get full text
-
7
Engineering kinetics of immunotherapies and vaccines
Published 2024“…Secondly, “extended dosing” of vaccines – immunization regimens that prolong exposure to antigen/adjuvant– has shown promise as a strategy to significantly augment humoral immune responses to HIV vaccines. …”
Get full text
Thesis -
8
-
9
-
10
-
11
-
12
-
13
-
14
Development of polymeric nanoparticle vaccines for immunostimulation
Published 2014Get full text
Thesis -
15
After Action Reports: Lessons on Vaccine Distribution
Published 2016“…For instance, the best distribution method for times of low supply of vaccine and high demand is one based on county populations within a state, while an online ordering system for vaccine performs well in times of high supply and lower demand. …”
Get full text
Working Paper -
16
Beyond antigens and adjuvants: formulating future vaccines
Published 2017“…The need to optimize vaccine potency while minimizing toxicity in healthy recipients has motivated studies of the formulation of vaccines to control how, when, and where antigens and adjuvants encounter immune cells and other cells/tissues following administration. …”
Get full text
Get full text
Get full text
Article -
17
Crystallization of a nonreplicating rotavirus vaccine candidate
Published 2021“…Nonreplicating rotavirus vaccine (NRRV) candidates are being developed with the aim of serving the needs of developing countries. …”
Get full text
Article -
18
Crystallization of a nonreplicating rotavirus vaccine candidate
Published 2022“…Nonreplicating rotavirus vaccine (NRRV) candidates are being developed with the aim of serving the needs of developing countries. …”
Get full text
Article -
19
In situ cancer vaccination using lipidoid nanoparticles
Published 2021“…<jats:p>In situ vaccination is a promising strategy for cancer immunotherapy owing to its convenience and the ability to induce numerous tumor antigens. …”
Get full text
Article -
20
In situ cancer vaccination using lipidoid nanoparticles
Published 2022“…<jats:p>In situ vaccination is a promising strategy for cancer immunotherapy owing to its convenience and the ability to induce numerous tumor antigens. …”
Get full text
Article